Vicarious Surgical

Vicarious Surgical, Inc. engages in advancing the field of surgical robotics. Through the use of surgical robotics, the company aims to improve patients lives, surgeons abilities, and expand global access to high-quality care. The company was founded by Adam Sachs and Sammy Khalifa on May 6, 2020 and is headquartered in Waltham, MA.

Earnings data Q1 2024

Vicarious Surgical reports increased expenses and strong cash position

Vicarious Surgical's Q1 2023 earnings call highlighted increased expenses, a strong cash position, and a focus on regulatory progress and system enhancements. The company faces challenges in managing risk factors and addressing various operational and regulatory issues. However, it also has opportunities for strategic investments and growth.

Vicarious Surgical advances towards Version 1.0 System manufacturing and regulatory plans

Vicarious Surgical is making significant progress towards manufacturing and testing its Version 1.0 System, with a focus on regulatory submission plans and the addition of a new hospital partner. However, challenges in managing cash burn rate and navigating the FDA authorization process persist. Despite this, the company is well-positioned to pursue upcoming milestones and capitalize on opportunities for growth.

RBOT reports decreased expenses and challenges in Q3 earnings

RBOT's Q3 earnings call highlighted a decrease in operating expenses, successes in partnerships and equity offerings, but also challenges in downsizing and integration setbacks. The company expressed confidence in overcoming challenges and emphasized the importance of efficiency, while also confirming pursuit of other indications and low risk to partnerships.

Vicarious Surgical excels in Q4 2023, poised for growth

Vicarious Surgical's Q4 2023 earnings call showcased strong performance, strategic advancements, and a clear roadmap for future growth. The company's focus on capital efficiency, regulatory milestones, and product development positions it well for success in the surgical technology market.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2024 after the market closes on Monday, April 29, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in l.

Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024

Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's Fourth Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your operator for today's call.

Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended December 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, March 4, 2024. “We made meaningful progress transitioning our Beta 2.

Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference. Management is scheduled to present on Tuesday, March 5, 2024 at 2:10 p.m. ET. A live webcast of the presentation will be accessible to th.

Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market closes on Monday, March 4, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investor.

Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0.

Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Piper Sandler 35th Annual Healthcare Conference. Management is scheduled to participate in a fireside chat on Tuesday, November 28, 2023, at 9:00 am ET. Interested parties can access a.

Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference

Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cohen Caitlin Cronin - Canaccord Genuity Operator Good afternoon, and welcome to Vicarious Surgical's Third Quarter 2023 Earnings Conference Call. My name is Kate, and I'll be your operator for today's call.

Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, November 13, 2023. “The third quarter brought several successes for our business,.

Vicarious Surgical Reports Third Quarter 2023 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter ended September 30, 2023, after the market closes on November 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in l.

Vicarious Surgical to Report Third Quarter 2023 Financial Results on November 13, 2023

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20, 2023, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average clo.

Vicarious Surgical Receives Continued Listing Standard Notice From NYSE

Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.

Vicarious Surgical (RBOT) to Broaden User Network With New Deal

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to enhance patient outcomes and improve the cost and efficiency of surgical procedures, announced it has signed a strategic development agreement with Intermountain Health, a leading U.S. healthcare system. Intermountain Health is a nonprofit system of 33 hospitals, 385 clinics, medical groups with some 4,300 employed physi.

Vicarious Surgical Announces New Hospital System Partnership with Intermountain Health

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Management is scheduled to participate in a fireside chat on Thursday, September 21, 2023, at 10:00 am ET. Inte.

Vicarious Surgical to Present at the Gilmartin Group Emerging Growth Company Showcase

Vicarious Surgical is a surgical robotics company developing a next-generation surgical robot with human-like dexterity. The company has a large addressable market of over 45 million abdominal procedures worth $150 billion, but its survival is uncertain due to low cash reserves and high burn. I am personally staying on the sidelines as I believe the risk / reward is better if/when RBOT reaches commercialization with a superior product than currently awaiting regulatory approval.

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference. Management is scheduled to present on Wednesday, August 9 at 2:30 p.m. ET. A live webcast of the presentation will be accessible to the.

Vicarious Surgical to Present at the Canaccord Genuity 43rd Annual Growth Conference

Vicarious Surgical shares plunged more than 40% after the robotics technology company announced a public offering of its shares at a steep discount to its share price at the time.   The company said it was offering 45 million shares at a price of $1, far below its then-share price of about $1.65.

Vicarious Surgical stock tanks on discounted public offering

Vicarious Surgical (NYSE: RBOT ) stock is falling on Thursday after the surgical robot company revealed details of a public offering. That public offering has Vicarious Surgical selling 45 million shares of RBOT stock at a price of $1 per share.

Why Is Vicarious Surgical (RBOT) Stock Down 41% Today?

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock (“Common Stock”) at a price to the public of $1.00 per share. In addition, Vicarious Surgical has granted the underwrite.

Vicarious Surgical Announces Pricing of Public Offering

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that it has commenced an underwritten public offering of $45.0 million of shares of its Class A common stock (“Common Stock”). All of the shares of Common Stock are being offered by Vicarious Surgical. In addition, th.

Vicarious Surgical Announces Launch of Proposed Public Offering

Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Kaitlyn Brosco - Investor Relations Conference Call Participants Simran Kaur - Piper Sandler Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's, Second Quarter 2023 Earnings Conference Call. My name is Sara, and I'll be your operator for today's call.

Vicarious Surgical Inc. (RBOT) Q2 2023 Earnings Call Transcript

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended June 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, July 27, 2023. “Following our latest pre-submission meeting with the FDA, we are thril.

Vicarious Surgical Reports Second Quarter 2023 Financial Results and Announces Clinical Plan and Regulatory Intent

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the second quarter ended June 30, 2023, after the market closes on Thursday, July 27, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in.

Vicarious Surgical to Report Second Quarter 2023 Financial Results on July 27, 2023

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the promotion of John Mazzola to Chief Operating Officer. John joined Vicarious Surgical in March of 2022 as SVP of Operations and has over 35 years of medical device industry experience. He has been involved with ove.

Vicarious Surgical Announces Promotion of John Mazzola to Chief Operating Officer

Vicarious Surgical, Inc. (NYSE:RBOT ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - Co-Founder, CEO, President & Director William Kelly - CFO & Treasurer Conference Call Participants Kyle Rose - Canaccord Operator Good afternoon, and welcome to Vicarious Surgical's First Quarter 2023 Earnings Conference Call. My name is Alisa, and I will be your operator for today's call.

News for Vicarious Surgical Stock (RBOT)